Yahoo Finance

TriLink BioTechnologies, part of Maravai LifeSciences, Expands R&D Leadership Team

SAN DIEGO, July 06, 2022 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI) and a leader in the production of nucleic acids for research, ...
Yahoo Finance

TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense

SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI), and a leader in the production of nucleic acids for research, ...
Yahoo Finance

TriLink to Open New GMP Facility Aimed at Early Phase Therapeutic Manufacturing

SAN DIEGO, CA--(Marketwired - May 21, 2014) - TriLink BioTechnologies (TriLink), a leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA, today announced their new 2 ...
Yahoo Finance

TriLink BioTechnologies, Inc. Announces New License Agreement With Biofortuna Ltd.

SAN DIEGO, CA--(Marketwired - Nov 6, 2013) - TriLink BioTechnologies, Inc. (TriLink) announced that it has signed a new licensing agreement with Biofortuna Ltd. (Biofortuna) for use of its CleanAmp™ ...
Business Wire

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center

SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, is collaborating with the ...
FiercePharma

TriLink BioTechnologies Announces Agreement with American Cleanroom Systems to build cGMP Facility

SAN DIEGO (October 22, 2013) - TriLink BioTechnologies (TriLink) announced that it has signed an agreement with American Cleanroom Systems (ACS) and Kelchlin Construction to build a 2,000 square foot ...
Nasdaq

Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services

New integrated offering will help to meet expected increases in global demand by simplifying and accelerating production of GMP-grade mRNA product for downstream vaccine and therapeutic manufacturing ...
PharmiWeb

TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada

SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink ®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted patents by ...
Nasdaq

Maravai LifeSciences' Cygnus & TriLink Unveil AccuRes DNA Kits

Maravai LifeSciences Holdings, Inc. MRVI, through its subsidiaries Cygnus Technologies and TriLink BioTechnologies, has announced the launch of AccuRes Host Cell DNA Quantification Kits. This latest ...
Business Wire

TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology

TriLink’s CleanCap technology produces optimal 5′ cap structures with over 95% efficiency, creating a co-transcriptional capping solution that dramatically improves mRNA yield and process time when ...
HUB

Johns Hopkins to establish new RNA innovation center in collaboration with TriLink BioTechnologies

Johns Hopkins University, home to considerable expertise in RNA sciences and therapeutic development, has announced a new academic collaboration with TriLink BioTechnologies, part of Maravai ...